We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+0.62%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$720M
AUM Growth
-$59.6M
Cap. Flow
-$36.5M
Cap. Flow %
-5.06%
Top 10 Hldgs %
17.21%
Holding
510
New
74
Increased
122
Reduced
203
Closed
86

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$4.08M
2
JBTM
JBT Marel
JBTM
+$3.91M
3
PRSU
Pursuit Attractions and Hospitality Inc
PRSU
+$3.66M
4
NOG icon
Northern Oil and Gas
NOG
+$3.45M
5
DVN icon
Devon Energy
DVN
+$3.09M

Top Sells

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$7.07M
2
RS icon
Reliance Steel & Aluminium
RS
+$5.93M
3
CHX
ChampionX
CHX
+$4.74M
4
ACN icon
Accenture
ACN
+$4.11M
5
ONON icon
On Holding
ONON
+$3.96M

Sector Composition

Rank Sector Weight
1 Technology 21.49%
2 Consumer Discretionary 17.64%
3 Industrials 15.79%
4 Healthcare 11.67%
5 Financials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
401
Illinois Tool Works
ITW
$82.1B
$257K 0.04%
1,114
-28
-2% -$6.83K
DKNG icon
402
DraftKings
DKNG
$11.9B
$255K 0.04%
8,669
+832
+11% +$24.6K
HUBS icon
403
HubSpot
HUBS
$11B
$254K 0.04%
515
-135
-21% -$70.5K
TWI icon
404
Titan International
TWI
$530M
$239K 0.03%
+17,832
New +$217K
SPY icon
405
State Street SPDR S&P 500 ETF Trust
SPY
$788B
$239K 0.03%
558
-5
-0.9% -$2.22K
SHY icon
406
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$236K 0.03%
2,915
+270
+10% +$21.9K
ASPN icon
407
Aspen Aerogels
ASPN
$401M
$222K 0.03%
+25,824
New +$183K
RCEL icon
408
Avita Medical
RCEL
$148M
$222K 0.03%
15,200
-31,894
-68% -$540K
CTLP
409
DELISTED
Cantaloupe
CTLP
$220K 0.03%
35,269
-38,209
-52% -$280K
ACWI icon
410
iShares MSCI ACWI ETF
ACWI
$32.7B
$220K 0.03%
+2,383
New +$229K
PD icon
411
PagerDuty
PD
$730M
$220K 0.03%
9,761
– –
SBDS
412
DELISTED
Solo Brands Inc
SBDS
$219K 0.03%
1,072
-3,104
-74% -$677K
BPMC
413
DELISTED
Blueprint Medicines
BPMC
$218K 0.03%
+4,332
New +$231K
WIRE
414
DELISTED
Encore Wire Corp
WIRE
$217K 0.03%
1,192
-7,296
-86% -$1.24M
BRLT icon
415
Brilliant Earth
BRLT
$19M
$213K 0.03%
72,153
-28,629
-28% -$103K
THR
416
DELISTED
Thermon Group Holdings
THR
$212K 0.03%
+7,705
New +$207K
TWST icon
417
Twist Bioscience
TWST
$5.91B
$210K 0.03%
10,378
-10,745
-51% -$236K
SHOP icon
418
Shopify
SHOP
$157B
$202K 0.03%
3,705
-5,766
-61% -$349K
TOST icon
419
Toast
TOST
$17.5B
$195K 0.03%
10,401
-39,309
-79% -$853K
TEVA icon
420
Teva Pharmaceuticals
TEVA
$36.4B
$185K 0.03%
+18,089
New +$168K
ATOM icon
421
Atomera
ATOM
$213M
$125K 0.02%
20,000
– –
BEAT icon
422
Heartbeam
BEAT
$28.9M
$108K 0.01%
50,000
-50,000
-50% -$127K
BTMD icon
423
Biote Corp
BTMD
$70.4M
$90.6K 0.01%
17,689
– –
MIR.WS
424
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$37.1K 0.01%
27,500
– –
ADSK icon
425
Autodesk
ADSK
$45.2B
– –
-1,201
Closed -$246K
15 16
17
18 19

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q3 2023 Portfolio in Review

As of Q3 2023, Advisory Research held 510 positions worth $720M, down 7.6% from $780M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Advisory Research withdrew a net $36.5M in Q3 2023, closing 86 positions and reducing 203 holdings. Its most notable exit was Livent Corporation, an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Advisory Research opened a new position in JBT Marel worth $3.67M.

  • Advisory Research's largest Q3 2023 buy was JBT Marel: 34,900 shares worth $3.67M.
  • Advisory Research added most to GSK in Q3 2023, an estimated $4.08M increase.
  • Advisory Research's biggest Q3 2023 reduction was Denbury Inc., cutting an estimated $7.07M.
  • Advisory Research fully exited Livent Corporation in Q3 2023, selling an estimated $2.81M.
  • Advisory Research's ten largest holdings make up 17% of its $720M portfolio in Q3 2023.
  • Advisory Research opened 74 new positions and closed 86 in Q3 2023.
  • Advisory Research's portfolio value fell 7.6% quarter-over-quarter to $720M.

Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.